Switching from Natalizumab to Anticd20 Monoclonal Antibodies: Short Transition Interval is Associated with Improved Outcome.
EUROPEAN JOURNAL OF NEUROLOGY(2025)
Key words
CD20,multiple sclerosis,natalizumab,prediction,risk,switch
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined